Cowen and Company’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,030
Closed -$152K 364
2024
Q3
$152K Buy
+15,030
New +$151K 0.01% 255

Other funds holding GPAT

Cowen and Company's GPAT Position: Q4 2024 in Review

Cowen and Company sold out of GP-Act III Acquisition Corp (GPAT) in Q4 2024, closing a stake of 15,030 shares — an estimated $152K sold.

Cowen and Company first reported a position in GPAT in Q3 2024 and held it in 1 quarter. The position peaked at $152K in Q3 2024. 42 funds tracked by Wall St. Rank hold GPAT as of Q4 2024.

  • Cowen and Company reported no remaining GP-Act III Acquisition Corp position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 15,030 GP-Act III Acquisition Corp shares in Q4 2024, an estimated $152K.
  • Cowen and Company first reported a position in GP-Act III Acquisition Corp in Q3 2024 and held it in 1 quarter.
  • Cowen and Company's GP-Act III Acquisition Corp position peaked at $152K in Q3 2024.
  • 42 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.